|Bid||32.00 x 1300|
|Ask||34.65 x 1100|
|Day's Range||32.92 - 35.52|
|52 Week Range||30.02 - 74.25|
|Beta (5Y Monthly)||1.22|
|PE Ratio (TTM)||27.46|
|Earnings Date||May 06, 2020 - May 10, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||66.92|
Alongside ACRO, Syneos Health to Provide Support for COVID-19 Testing Centers;Company Continues Public Service Educational Program to Address Ventilator Shortage MORRISVILLE,.
The best health care stocks to watch have several commonalities including a streak of earnings growth. It's important to keep tabs on high-ranking health care stocks with strong metrics.
Over the first quarter of 2020, more than $31 billion in value disappeared from the books of local public companies that collectively employ more than a hundred thousand workers in the Triangle and across the U.S.
A Morrisville-based contract research organization is spreading the word about a COVID-19 treatment using a common hospital apparatus in order to stem off some of the demand for ventilators in low supply.
Medical stocks have struggled this year. But the best performing among them include medical technology companies that tend to have high Composite Ratings, a key metric measuring growth.
The primary aim of this initiative by Syneos Health (SYNH) is to address the predicted ventilator deficiency in the wake of the coronavirus pandemic.
www.COVID-BiPAPInfo.com Provides Practical Information for Physicians on Innovative Use of BiPAP Machines – Already Available in Many Hospitals – to Potentially Delay or Remove.
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted that a US recession is imminent and US stocks will go down by at least 20% in the next 3-6 […]
Potential Syneos Health, Inc. (NASDAQ:SYNH) shareholders may wish to note that the Chief Financial Officer, Jason...
Syneos Health (SYNH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Unfortunately for some shareholders, the Syneos Health (NASDAQ:SYNH) share price has dived 34% in the last thirty...
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a...
Global concerns over the spread of the novel coronavirus rocked stock markets on Monday. The spread of COVID-19 has been a major economic punch felt around the globe, and it's impacting production at Triangle firms – from Lenovo to Cree.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Feb. 20.) Akebia Therapeutics Inc (NASDAQ: AKBA ) Aptose Biosciences ...
Another giant among Triangle contract research organizations (CRO) has reported revenue in excess of guidance closing on 2019, but its executives say the only way forward is through continual expansion and improvement.
Highlights GAAP revenue of $1,213.0 million and $4,675.8 million for the three and twelve months ended December 31, 2019, representing growth of 5.9% and 6.5% compared to the.
NEW YORK, NY / ACCESSWIRE / February 20, 2020 / Syneos Health, Inc. (NASDAQ:SYNH) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on February 20, 2020 at ...
One of Raleigh and Durham's more prominent subsets in its burgeoning life sciences is contract research. And this area has become a hotbed for those companies and the workers they attract. The CRO industry is the subject of one of Triangle Business Journal’s lists this week.
Syneos Health (SYNH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MORRISVILLE, N.C., Jan. 22, 2020 -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its fourth quarter and year.